Marex Group’s Tectonic Therapeutic TECX Stock Holding History

Marex Group’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,501	Closed	-$261K	–	1278
2025 Q4	$261K	Buy	+12,501	New	+$232K	﹤0.01%	751

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Marex Group's TECX Position: Q1 2026 in Review

Marex Group sold out of Tectonic Therapeutic (TECX) in Q1 2026, closing a stake of 12,501 shares — an estimated $261K sold.

Marex Group first reported a position in TECX in Q4 2025 and held it in 1 quarter. The position peaked at $261K in Q4 2025. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

Marex Group reported no remaining Tectonic Therapeutic position as of Q1 2026 after selling out during the quarter.
Marex Group sold 12,501 Tectonic Therapeutic shares in Q1 2026, an estimated $261K.
Marex Group first reported a position in Tectonic Therapeutic in Q4 2025 and held it in 1 quarter.
Marex Group's Tectonic Therapeutic position peaked at $261K in Q4 2025.
111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.